Steve Coats
Impact in
- Oncology top 2%
- Cancer-related Molecular Pathways
- Cell Biology top 5%
- Microtubule and mitosis dynamics
Papers in
-
- Ubiquitin and proteasome pathways 5
- Epigenetics and DNA Methylation 4
- Oncology 12
- Cancer-related Molecular Pathways 8
- CAR-T cell therapy research 3
- Co-authors
- Jamison L. Nourse (2 shared papers)W. Michael Flanagan (2 shared papers)James M. Roberts (1 shared paper)Eduardo Firpo (2 shared papers)James M. Roberts (2 shared papers)Gerald R. Crabtree (1 shared paper)Kornélia Polyák (1 shared paper)Joan Massagué (1 shared paper)
- Journals
- Cancer Research (2 papers)Molecular Cancer Therapeutics (2 papers)Current Biology (1 paper)Cancers (1 paper)mAbs (1 paper)
- Partner nations
- United StatesGermanySouth Africa
In The Last Decade
Steve Coats
17 papers receiving 2.3k citations
Steve Coats's Hit Papers
Peers
Comparison fields: 5 of 83
- Oncology 1.4k
- Cell Biology 379
- Molecular Biology 1.5k
- Cancer Research 265
- Immunology 302
Countries citing papers authored by Steve Coats
This map shows the geographic impact of Steve Coats's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Coats with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Coats more than expected).
Fields of papers citing papers by Steve Coats
This network shows the impact of papers produced by Steve Coats. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Coats. The network helps show where Steve Coats may publish in the future.
Co-authors
The 25 scholars most cited alongside Steve Coats, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | lnterleukin-2-mediated elimination of the p27Kipl cyclin-dependent kinase inhibitor prevented by rapamycin Hit paper breakdown → | 1994 | 806 |
| 2 | Requirement of p27 Kip1 for Restriction Point Control of the Fibroblast Cell Cycle Hit paper breakdown → | 1996 | 609 |
| 3 | Regulation of the cell cycle machinery by oncogenic ras. | 1996 | 171 |
| 4 | 1999 | 155 | |
| 5 | 1999 | 107 | |
| 6 | 2006 | 84 | |
| 7 | 2014 | 72 | |
| 8 | 2007 | 66 | |
| 9 | 2006 | 62 | |
| 10 | 2012 | 59 | |
| 11 | 2002 | 46 | |
| 12 | 2002 | 46 | |
| 13 | 2009 | 34 | |
| 14 | Characterization of platelet-derived growth factor alpha receptor synthesis and metabolic turnover. | 1994 | 6 |
| 15 | Preclinical efficacy and safety models for mAbs: the challenge of developing effective model systems. | 2009 | 4 |
| 16 | 2024 | 2 | |
| 17 | 2006 | 1 | |
| 18 | 2004 | 1 |
About Steve Coats
Steve Coats is a scholar working on Molecular Biology, Oncology, Cell Biology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 18 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (8 papers), Ubiquitin and proteasome pathways (5 papers), Epigenetics and DNA Methylation (4 papers), Microtubule and mitosis dynamics (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), CAR-T cell therapy research (3 papers), Axon Guidance and Neuronal Signaling (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Oncology (1.4k citations), Cell Biology (379 citations), Molecular Biology (1.5k citations), Cancer Research (265 citations) and Immunology (302 citations). Steve Coats has collaborated with scholars based in United States, Germany and South Africa. Frequent co-authors include Jamison L. Nourse, W. Michael Flanagan, James M. Roberts, Eduardo Firpo, James M. Roberts, Gerald R. Crabtree, Kornélia Polyák, Joan Massagué, Mong‐Hong Lee and Marc Payton. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Current Biology, Cancers and mAbs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.